CXCL12 was shown to increase the migration of lung cancer cells through the CXCR4-mediated activation of ERK, which in turn activates IKKa/b and NF-κB, resulting in the activations of integrins (ITGB1 and ITGB3) [22]. This evidence concerns the gene MAPK1 and lung cancer.